Cardiff Oncology Inc. (CRDF) Stock Price

2.88 ▲ +0.09 (+3.23%)
Open: 2.80 Vol: 771.4K Day's range: 2.78 - 3.02 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CRDF Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.90▼ 2.92▼ 2.94▼ 2.84▲ 2.87▲
MA10 2.91▼ 2.96▼ 2.91▼ 2.95▼ 2.53▲
MA20 2.92▼ 2.90▼ 2.85▲ 2.90▼ 2.35▲
MA50 2.96▼ 2.85▲ 2.94▼ 2.49▲ 2.94▼
MA100 2.89▲ 2.93▼ 2.93▼ 2.33▲ 3.10▼
MA200 2.84▲ 2.92▼ 2.66▲ 2.72▲ 2.39▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.004▼ -0.005▼ 0.014▲ -0.039▼ 0.130▲
RSI 24.833▼ 48.604▼ 49.681▼ 54.557▲ 54.055▲
STOCH 16.548▼ 32.157     74.193     37.274     77.547    
WILL %R -76.471▼ -51.064     -42.857     -60.967     -30.496    
CCI -124.324▼ -77.383     14.902     -15.240     106.371▲
Latest Filters Detected On CRDF
CDL $CRDF Doji Candlestick Pattern Detected Set Alert
Cardiff Oncology Inc. News
Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm
Tuesday, January 13, 2026 06:48 AM
Cardiff Oncology (CRDF) remains a single-asset biotech, with its thesis reliant on onvansertib targeting PLK1 in difficult-to-treat cancers.
Cardiff Presents Phase 1 Data Of Onvensertib In Chronic Myelomonocytic Leukemia At ASH 2025
Monday, December 08, 2025 11:44 PM
(RTTNews) - Cardiff Oncology, Inc. (CRDF) has presented new clinical data from an investigator-sponsored Phase 1 dose escalation trial evaluating onvansertib, a novel oral PLK1 inhibitor, in patients ...
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
Monday, December 08, 2025 01:05 PM
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of ...
CRDF historical stock data
date open high low close volume
16/01/26 2.80 3.02 2.78 2.88 771,400
15/01/26 2.80 2.84 2.72 2.79 405,600
14/01/26 2.87 2.87 2.75 2.81 572,600
13/01/26 2.88 2.90 2.78 2.87 470,700
12/01/26 3.08 3.08 2.82 2.87 837,800
09/01/26 3.19 3.30 3.07 3.08 1,054,000
08/01/26 3.14 3.30 3.10 3.17 1,348,500
07/01/26 2.97 3.30 2.97 3.21 1,759,200
06/01/26 2.83 2.98 2.71 2.97 1,361,800
05/01/26 2.69 2.90 2.64 2.84 950,500
Quote Details
52wk Low:1.90
52wk High:4.99
Vol:771.4K
Avg Vol(3m):15.7M
1Y Chng:-32.55%
1M Chng:+33.33%
Add to Watch List
More Information
Index US Composite
Market Cap. 187.94M